Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that develops a drug discovery platform and pipeline with machine learning. The company is headquartered in Salt Lake City, Utah, United States, and was founded in 2013. Recursion Pharmaceuticals integrates technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company aims to decode biology and radically improve the lives of patients.
Recursion Pharmaceuticals has raised a total of $509.79 million in funding. The company's stock ticker symbol is RXRX, and it is listed on the NasdaqGS exchange. As of May 6, 2024, the company's stock closed at $7.84, marking a -1.26% move from the prior day. Nvidia owns a 3.4% stake in the company.
Recursion Pharmaceuticals has 37 investors, including:
Recursion Pharmaceuticals has 571 employees.